Therapeutic Autologous Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
This study has been terminated.
Study NCT00052598
Information provided by Fred Hutchinson Cancer Research Center
First Received on January 24, 2003.
Last Updated on July 12, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
